Altered cortical thickness development in 22q11.2 deletion syndrome and association with psychotic symptoms.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
12 2021
Historique:
received: 07 10 2020
accepted: 23 06 2021
revised: 15 06 2021
pubmed: 14 7 2021
medline: 15 3 2022
entrez: 13 7 2021
Statut: ppublish

Résumé

Schizophrenia has been extensively associated with reduced cortical thickness (CT), and its neurodevelopmental origin is increasingly acknowledged. However, the exact timing and extent of alterations occurring in preclinical phases remain unclear. With a high prevalence of psychosis, 22q11.2 deletion syndrome (22q11DS) is a neurogenetic disorder that represents a unique opportunity to examine brain maturation in high-risk individuals. In this study, we quantified trajectories of CT maturation in 22q11DS and examined the association of CT development with the emergence of psychotic symptoms. Longitudinal structural MRI data with 1-6 time points were collected from 324 participants aged 5-35 years (N = 148 22q11DS, N = 176 controls), resulting in a total of 636 scans (N = 334 22q11DS, N = 302 controls). Mixed model regression analyses were used to compare CT trajectories between participants with 22q11DS and controls. Further, CT trajectories were compared between participants with 22q11DS who developed (N = 61, 146 scans), or remained exempt of (N = 47; 98 scans) positive psychotic symptoms during development. Compared to controls, participants with 22q11DS showed widespread increased CT, focal reductions in the posterior cingulate gyrus and superior temporal gyrus (STG), and accelerated cortical thinning during adolescence, mainly in frontotemporal regions. Within 22q11DS, individuals who developed psychotic symptoms showed exacerbated cortical thinning in the right STG. Together, these findings suggest that genetic predisposition for psychosis is associated with increased CT starting from childhood and altered maturational trajectories of CT during adolescence, affecting predominantly frontotemporal regions. In addition, accelerated thinning in the STG may represent an early biomarker associated with the emergence of psychotic symptoms.

Identifiants

pubmed: 34253864
doi: 10.1038/s41380-021-01209-8
pii: 10.1038/s41380-021-01209-8
pmc: PMC8873018
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7671-7678

Informations de copyright

© 2021. The Author(s).

Références

Hulshoff Pol HE, Kahn RS. What happens after the first episode? A review of progressive brain changes in chronically Ill patients with schizophrenia. Schizophr Bull. 2008;34:354–66.
pubmed: 18283048 pmcid: 2632411 doi: 10.1093/schbul/sbm168
Fornito A, Yücel M, Patti J, Wood SJ, Pantelis C. Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res. 2009;108:104–13.
pubmed: 19157788 doi: 10.1016/j.schres.2008.12.011
Olabi B, Ellison-Wright I, McIntosh AM, Wood SJ, Bullmore E, Lawrie SM. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry. 2011;70:88–96.
pubmed: 21457946 doi: 10.1016/j.biopsych.2011.01.032
Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry. 2008;165:1015–23.
pubmed: 18381902 pmcid: 2873788 doi: 10.1176/appi.ajp.2008.07101562
Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ. Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev. 2012;36:1342–56.
pubmed: 22244985 doi: 10.1016/j.neubiorev.2011.12.015
van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, et al. Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through meta analysis (ENIGMA) consortium. Biol Psychiatry. 2018;84:644–54.
pubmed: 29960671 pmcid: 6177304 doi: 10.1016/j.biopsych.2018.04.023
Glausier JR, Lewis DA. Dendritic spine pathology in schizophrenia. Neuroscience 2013;251:90–107.
pubmed: 22546337 doi: 10.1016/j.neuroscience.2012.04.044
Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TGM, et al. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry. 2015;77:147–57.
pubmed: 25034946 doi: 10.1016/j.biopsych.2014.05.023
Chung Y, Cannon TD. Brain imaging during the transition from psychosis prodrome to schizophrenia. J Nerv Ment Dis. 2015;203:336–41.
pubmed: 25900551 pmcid: 4414922 doi: 10.1097/NMD.0000000000000286
McIntosh AM, Owens DC, Moorhead WJ, Whalley HC, Stanfield AC, Hall J, et al. Longitudinal volume reductions in people at high genetic risk of schizophrenia as they develop psychosis. Biol Psychiatry. 2011;69:953–8.
pubmed: 21168123 doi: 10.1016/j.biopsych.2010.11.003
Andreou C, Borgwardt S. Structural and functional imaging markers for susceptibility to psychosis. Mol Psychiatry. 2020;25:2773–85.
Insel TR. Rethinking schizophrenia. Nature. 2010;468:187–93.
pubmed: 21068826 doi: 10.1038/nature09552
Bassett AS, Chow EWC. 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry. 1999;46:882–91.
pubmed: 10509171 pmcid: 3276595 doi: 10.1016/S0006-3223(99)00114-6
Schmitt JE, Vandekar S, Yi J, Calkins ME, Ruparel K, Roalf DR, et al. Aberrant cortical morphometry in the 22q11.2 deletion syndrome. Biol Psychiatry. 2015;78:135–43.
pubmed: 25555483 doi: 10.1016/j.biopsych.2014.10.025
Jalbrzikowski M, Jonas R, Senturk D, Patel A, Chow C, Green MF, et al. Structural abnormalities in cortical volume, thickness, and surface area in 22q11.2 microdeletion syndrome: relationship with psychotic symptoms. NeuroImage Clin. 2013;3:405–15.
pubmed: 24273724 pmcid: 3814944 doi: 10.1016/j.nicl.2013.09.013
Gudbrandsen M, Daly E, Murphy CM, Blackmore CE, Rogdaki M, Mann C, et al. Brain morphometry in 22q11.2 deletion syndrome: an exploration of differences in cortical thickness, surface area, and their contribution to cortical volume. Sci Rep. 2020;10:18845.
pubmed: 33139857 pmcid: 7606591 doi: 10.1038/s41598-020-75811-1
Sun D, Ching CRK, Lin A, Forsyth JK, Kushan L, Vajdi A, et al. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size. Mol Psychiatry. 2020;25:1822–34.
Tang SX, Gur RE. Longitudinal perspectives on the psychosis spectrum in 22q11.2 deletion syndrome. Am J Med Genet A. 2018;176:2192–202.
pubmed: 29048724 doi: 10.1002/ajmg.a.38500
Schaer M, Debbané M, Bach Cuadra M, Ottet M-C, Glaser B, Thiran J-P, et al. Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study. Schizophr Res. 2009;115:182–90.
pubmed: 19836927 doi: 10.1016/j.schres.2009.09.016
Ramanathan S, Mattiaccio LM, Coman IL, Botti J-AC, Fremont W, Faraone SV, et al. Longitudinal trajectories of cortical thickness as a biomarker for psychosis in individuals with 22q11.2 deletion syndrome. Schizophr Res. 2017;188:35–41.
pubmed: 27988073 doi: 10.1016/j.schres.2016.11.041
Kates WR, Antshel KM, Faraone SV, Fremont WP, Higgins AM, Shprintzen RJ, et al. Neuroanatomic predictors to prodromal psychosis in velocardiofacial syndrome (22q11.2 deletion syndrome): a longitudinal study. Biol Psychiatry. 2011;69:945–52.
pubmed: 21195387 doi: 10.1016/j.biopsych.2010.10.027
Gothelf D, Hoeft F, Ueno T, Sugiura L, Lee AD, Thompson P, et al. Developmental changes in multivariate neuroanatomical patterns that predict risk for psychosis in 22q11.2 deletion syndrome. J Psychiatr Res. 2011;45:322–31.
pubmed: 20817203 pmcid: 3000448 doi: 10.1016/j.jpsychires.2010.07.008
Padula MC, Schaer M, Armando M, Sandini C, Zöller D, Scariati E, et al. Cortical morphology development in patients with 22q11.2 deletion syndrome at ultra-high risk of psychosis. Psychological Medicine. 2018;48:2375–83.
Radoeva PD, Bansal R, Antshel KM, Fremont W, Peterson BS, Kates WR. Longitudinal study of cerebral surface morphology in youth with 22q11.2 deletion syndrome, and association with positive symptoms of psychosis. J Child Psychol Psychiatry. 2017;58:305–14.
pubmed: 27786353 doi: 10.1111/jcpp.12657
Rimol LM, Nesvåg R, Hagler DJ, Bergmann Ø, Fennema-Notestine C, Hartberg CB, et al. Cortical volume, surface area, and thickness in schizophrenia and bipolar disorder. Biol Psychiatry. 2012;71:552–60.
pubmed: 22281121 doi: 10.1016/j.biopsych.2011.11.026
Palaniyappan L, Mallikarjun P, Joseph V, White TP, Liddle PF. Regional contraction of brain surface area involves three large-scale networks in schizophrenia. Schizophr Res. 2011;129:163–8.
pubmed: 21497489 doi: 10.1016/j.schres.2011.03.020
Schneider M, Schaer M, Mutlu AK, Menghetti S, Glaser B, Debbané M, et al. Clinical and cognitive risk factors for psychotic symptoms in 22q11.2 deletion syndrome: a transversal and longitudinal approach. Eur Child Adolesc Psychiatry. 2014;23:425–36.
pubmed: 23999732 doi: 10.1007/s00787-013-0469-8
McGlashan T, Walsh B, Woods S. The psychosis-risk syndrome: handbook for diagnosis and follow-up. Oxford University Press; 2010.
Tange O. Gnu parallel-the command-line power tool. USENIX Mag. 2011;36:42–7.
Maeder J, Schneider M, Bostelmann M, Debbané M, Glaser B, Menghetti S, et al. Developmental trajectories of executive functions in 22q11.2 deletion syndrome. J Neurodev Disord. 2016;8:10.
pubmed: 27018204 pmcid: 4807556 doi: 10.1186/s11689-016-9141-1
Mancini V, Sandini C, Padula MC, Zöller D, Schneider M, Schaer M, et al. Positive psychotic symptoms are associated with divergent developmental trajectories of hippocampal volume during late adolescence in patients with 22q11DS. Mol Psychiatry. 2019. http://www.nature.com/articles/s41380-019-0443-z . Accessed 4 Jul 2019.
Mutlu AK, Schneider M, Debbané M, Badoud D, Eliez S, Schaer M. Sex differences in thickness, and folding developments throughout the cortex. NeuroImage. 2013;82:200–7.
pubmed: 23721724 doi: 10.1016/j.neuroimage.2013.05.076
Hagler DJ, Saygin AP, Sereno MI. Smoothing and cluster thresholding for cortical surface-based group analysis of fMRI data. NeuroImage. 2006;33:1093–103.
pubmed: 17011792 doi: 10.1016/j.neuroimage.2006.07.036
Rakic P. Evolution of the neocortex: a perspective from developmental biology. Nat Rev Neurosci. 2009;10:724–35.
pubmed: 19763105 pmcid: 2913577 doi: 10.1038/nrn2719
Kiehl TR, Chow EWC, Mikulis DJ, George SR, Bassett AS. Neuropathologic features in adults with 22q11.2 deletion syndrome. Cereb Cortex. 2009;19:153–64.
pubmed: 18483005 doi: 10.1093/cercor/bhn066
Meechan DW, Tucker ES, Maynard TM, LaMantia A-S. Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome. Proc Natl Acad Sci USA. 2012;109:18601–6.
pubmed: 23091025 pmcid: 3494945 doi: 10.1073/pnas.1211507109
Walhovd KB, Fjell AM, Giedd J, Dale AM, Brown TT. Through thick and thin: a need to reconcile contradictory results on trajectories in human cortical development. Cereb Cortex. 2017. https://academic.oup.com/cercor/article/27/2/bhv301/3056211 . Accessed 10 Apr 2020.
Spear LP. Adolescent neurodevelopment. J Adolesc Health. 2013;52:S7–13.
pubmed: 23332574 pmcid: 3982854 doi: 10.1016/j.jadohealth.2012.05.006
Natu VS, Gomez J, Barnett M, Jeska B, Kirilina E, Jaeger C, et al. Apparent thinning of human visual cortex during childhood is associated with myelination. Proc Natl Acad Sci USA. 2019;116:20750–9.
pubmed: 31548375 pmcid: 6789966 doi: 10.1073/pnas.1904931116
Moutin E, Nikonenko I, Stefanelli T, Wirth A, Ponimaskin E, De Roo M, et al. Palmitoylation of cdc42 promotes spine stabilization and rescues spine density deficit in a mouse model of 22q11.2 deletion syndrome. Cereb Cortex. 2017;27:3618–29.
pubmed: 27365300
Mukherjee A, Carvalho F, Eliez S, Caroni P. Long-lasting rescue of network and cognitive dysfunction in a genetic schizophrenia model. Cell. 2019;178:1387–1402. e14
pubmed: 31474363 doi: 10.1016/j.cell.2019.07.023
Forsyth JK, Mennigen E, Lin A, Sun D, Vajdi A, Kushan-Wells L, et al. Prioritizing Genetic Contributors to Cortical Alterations in 22q11.2 Deletion Syndrome Using Imaging Transcriptomics. Cerebral Cortex. 2021;31:3285–98.
Bagautdinova J, Padula MC, Zöller D, Sandini C, Schneider M, Schaer M, et al. Identifying neurodevelopmental anomalies of white matter microstructure associated with high risk for psychosis in 22q11.2DS. Transl Psychiatry. 2020;10:1–15.
doi: 10.1038/s41398-020-01090-z
Schreiner MJ, Lazaro MT, Jalbrzikowski M, Bearden CE. Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome. Neuropharmacology 2013;68:157–73.
pubmed: 23098994 doi: 10.1016/j.neuropharm.2012.09.012
Fjell AM, Grydeland H, Krogsrud SK, Amlien I, Rohani DA, Ferschmann L, et al. Development and aging of cortical thickness correspond to genetic organization patterns. Proc Natl Acad Sci USA. 2015;112:15462–7.
pubmed: 26575625 pmcid: 4687601 doi: 10.1073/pnas.1508831112
Neniskyte U, Gross CT. Errant gardeners: glial-cell-dependent synaptic pruning and neurodevelopmental disorders. Nat Rev Neurosci. 2017;18:658–70.
pubmed: 28931944 doi: 10.1038/nrn.2017.110
Chow EWC, Ho A, Wei C, Voormolen EHJ, Crawley AP, Bassett AS. Association of schizophrenia in 22q11.2 deletion syndrome and gray matter volumetric deficits in the superior temporal gyrus. Am J Psychiatry. 2011;168:522–9.
pubmed: 21362743 pmcid: 3283577 doi: 10.1176/appi.ajp.2010.10081230
Fusar-Poli P, Borgwardt S, Crescini A, Deste G, Kempton MJ, Lawrie S, et al. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev. 2011;35:1175–85.
pubmed: 21168439 doi: 10.1016/j.neubiorev.2010.12.005
Walton E, Hibar DP, Erp TGM, van Potkin SG, Roiz‐Santiañez R, Crespo‐Facorro B, et al. Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA schizophrenia consortium. Acta Psychiatr Scand. 2017;135:439–47.
pubmed: 28369804 pmcid: 5399182 doi: 10.1111/acps.12718
Vita A, De Peri L, Deste G, Sacchetti E. Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry. 2012;2:e190–e190.
pubmed: 23168990 pmcid: 3565772 doi: 10.1038/tp.2012.116
Pantelis C, Velakoulis D, Wood SJ, Yücel M, Yung AR, Phillips LJ, et al. Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. Int Rev Psychiatry. 2007;19:371–9.
pubmed: 17671870 doi: 10.1080/09540260701512079
Mancini V, Zöller D, Schneider M, Schaer M, Eliez S. Abnormal development and dysconnectivity of distinct thalamic nuclei in patients with 22q11.2 deletion syndrome experiencing auditory hallucinations. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020. http://www.sciencedirect.com/science/article/pii/S2451902220301099 . Accessed 19 Jun 2020.
Shafee R, Buckner RL, Fischl B. Gray matter myelination of 1555 human brains using partial volume corrected MRI images. NeuroImage. 2015;105:473–85.
pubmed: 25449739 doi: 10.1016/j.neuroimage.2014.10.054

Auteurs

Joëlle Bagautdinova (J)

Developmental Imaging and Psychopathology Laboratory, Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland. joelle.vandermolen@unige.ch.

Daniela Zöller (D)

Developmental Imaging and Psychopathology Laboratory, Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Medical Image Processing Laboratory, Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Department of Radiology and Medical Informatics, University of Geneva, Geneva, Switzerland.

Marie Schaer (M)

Developmental Imaging and Psychopathology Laboratory, Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Maria Carmela Padula (MC)

Developmental Imaging and Psychopathology Laboratory, Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Valentina Mancini (V)

Developmental Imaging and Psychopathology Laboratory, Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Maude Schneider (M)

Developmental Imaging and Psychopathology Laboratory, Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Clinical Psychology Unit for Intellectual and Developmental Disabilities, Faculty of Psychology and Educational Sciences, University of Geneva, Geneva, Switzerland.

Stephan Eliez (S)

Developmental Imaging and Psychopathology Laboratory, Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH